Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,448 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 1-19 of 19 matching filings.

Per page
25
Current page
1
SC 13D/A

SC 13D/A

Filing date
27 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D

SC 13D

Filing date
18 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

SC 13D/A

Filing date
17 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

SC 13D/A

Filing date
29 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

SC 13D/A

Filing date
09 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

SC 13D/A

Filing date
09 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

SANOFI SC 13DA NO 12 1-31-2017 (REGENERON PHARMACEUTICALS, INC)

Filing date
31 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

SANOFI SC 13D/A NO 11 12-29-2015 (REGENERON PHARMACEUTICALS INC)

Filing date
29 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

AMENDMENT NO. 10

Filing date
17 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

AMENDMENT NO. 9

Filing date
31 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

SANOFI SC 13DA NO 8 7-7-2014 (REGENERON PHARMACEUTICALS, INC.)

Filing date
09 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

SANOFI SC 13DA NO. 7 6-27-2014 (REGENERON PHARMACEUTICALS, INC.)

Filing date
01 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

AMENDMENT NO. 6

Filing date
09 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

AMENDMENT NO. 5

Filing date
08 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

AMENDMENT NO. 4

Filing date
27 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

AMENDMENT NO. 3

Filing date
14 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

AMENDMENT NO. 2

Filing date
05 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-41938

AMENDMENT NO.1

Filing date
29 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-41938

SC 13D filing

Filing date
14 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .